Prior Sternotomy and Ventricular Assist Device Implantation Do Not Adversely Impact Survival or Allograft Function After Heart Transplantation Ann C.

Slides:

Advertisements

Similar presentations

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Advertisements

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

What Predicts Long-Term Survival After Heart Transplantation

Elizabeth A. David, MD, David T

Darrell Wu, MD, Matt D. Price, MS, Hiruni S. Amarasekara, MS, Susan Y

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD,

Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular.

Combined Heart and Liver Transplantation Can Be Safely Performed With Excellent Short- and Long-Term Results Pavan Atluri, MD, Ann Gaffey, MD, Jessica.

Laura Harvey, MD, Christopher Holley, MD, Samit S

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Andreas Zierer, MD, Spencer J. Melby, MD, Rochus K

Video-Assisted Thoracoscopic Left Ventricular Pacing in Patients With and Without Previous Sternotomy Katharine E. Nelson, MBBS, MRCP, Matthew G.D. Bates,

Predicting Right Ventricular Failure in the Modern, Continuous Flow Left Ventricular Assist Device Era Pavan Atluri, MD, Andrew B. Goldstone, MD, Alex.

Dhaval Chauhan, MD, Alexis K

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Minimally invasive mitral valve surgery is associated with equivalent cost and shorter hospital stay when compared with traditional sternotomy Pavan.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

The Impact of Specific Preoperative Organ Dysfunction in Patients Undergoing Aortic Valve Replacement Vinod H. Thourani, MD, Ritam Chowdhury, MD, Rebecca.

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Improved Approach With Subcostal Exchange of the HeartMate II Left Ventricular Assist Device: Difference in On and Off Pump? Ann C. Gaffey, MD, MTR,

Isaac George, MD, Steve Xydas, MD, Veli K

Less Is More in Post Pediatric Heart Transplant Care

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Matthew L. Williams, MD, Joseph E. Bavaria, MD, Michael A

Age-Related Outcomes of the Ross Procedure Over 20 Years

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Survival of Patients With or Without Symptoms Undergoing Potentially Curative Resections for Primary Lung Cancer Andrea R.G. Sheel, BS (Hons), MBChB,

Darrell Wu, MD, Matt D. Price, MS, Hiruni S. Amarasekara, MS, Susan Y

Postoperative Recurrence of Mitral Regurgitation After Annuloplasty for Functional Mitral Regurgitation Lawrence S. Lee, MD, Michael H. Kwon, MD, Marisa.

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Reversible Pulmonary Hypertension in Heart Transplant Candidates: To Transplant or Not to Transplant Stefan Klotz, MD, Frauke Wenzelburger, MD, Joerg.

Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C

Origins of the Cardiothoracic Surgery Network (CTSNet)

A “Repair-All” Strategy for Degenerative Mitral Valve Disease Safely Minimizes Unnecessary Replacement Andrew B. Goldstone, MD, Jeffrey E. Cohen, MD,

Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle Masashi Kawabori, MD, Chitaru Kurihara, MD, Tadahisa.

Use of Amiodarone After Major Lung Resection

Management of Subcutaneous Emphysema After Pulmonary Resection

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Bleeding, Transfusion, and Mortality on Extracorporeal Life Support: ECLS Working Group on Thrombosis and Hemostasis Michael Mazzeffi, MD, MPH, John.

Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea.

Interaction of Donor and Recipient Age: Do Older Heart Transplant Recipients Require Younger Hearts? Malini Daniel, MD, Carol Chen, MD, Jennifer Chung,

Acute Kidney Injury Increases Mortality After Lung Transplantation

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Arman Kilic, MD, Eric S. Weiss, MD, MPH, Jeremiah G

Raheel Rizwan, MD, Farhan Zafar, MD, Roosevelt Bryant, MD, James S

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Mechanical Circulatory Support Pathways That Maximize Post-Heart Transplant Survival Tara Karamlou, MD, MS, Jill Gelow, MD, Brian S. Diggs, PhD, Frederick.

William M. Whited, MD, Paul Henley, BS, Erin M

Absent Long-Term Benefit of Patch Versus Linear Reconstruction in Left Ventricular Aneurysm Surgery Ruediger Lange, MD, Thomas Guenther, MD, Norbert.

Asvin M. Ganapathi, MD, Paul J. Speicher, MD, Anthony W

Pretransplant Panel Reactive Antibodies in Human Lung Transplantation: An Analysis of Over 10,000 Patients Ashish S. Shah, MD, Lois Nwakanma, MD, Christopher.

A. Thomas Pezzella, MD, Sari D

Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure Erin M. Schumer,

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T.

Preoperative Performance Status Impacts Perioperative Morbidity and Mortality After Lung Transplantation Joshua C. Grimm, MD, Vicente Valero, MD, Arman.

The Impact of Volume Reduction on Early and Long-Term Outcomes in Surgical Ventricular Restoration for Severe Heart Failure Nathan Wm. Skelley, BS, Jeremiah.

Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy Ranjit.

Farhan Zafar, MD, John L. Jefferies, MD, MPH, Christine J

Creation of a Quantitative Score to Predict the Need for Mechanical Support in Children Awaiting Heart Transplant Ryan R. Davies, MD, Shylah Haldeman,

Y. Joseph Woo, MD, Michael A. Acker, MD The Annals of Thoracic Surgery

Use of Ventricular Assist Devices in Children Across the United States: Analysis of 7.5 Million Pediatric Hospitalizations David L.S. Morales, MD, Farhan.

Ventricular Assist Device Implant in the Elderly Is Associated With Increased, but Respectable Risk: A Multi-Institutional Study Pavan Atluri, MD, Andrew.

Costs Associated With Ventricular Assist Device Use in Children

Mark I. Block, MD The Annals of Thoracic Surgery

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Significance of Postoperative Acute Renal Failure After Continuous-Flow Left Ventricular Assist Device Implantation Jamil Borgi, MD, Athanasios Tsiouris,

Presentation transcript:

Prior Sternotomy and Ventricular Assist Device Implantation Do Not Adversely Impact Survival or Allograft Function After Heart Transplantation Ann C. Gaffey, MD, Emily C. Phillips, BA, Jessica Howard, BS, George Hung, BA, Jason Han, BS, Robert Emery, BS, Lee Goldberg, MD, Michael A. Acker, MD, Y. Joseph Woo, MD, Pavan Atluri, MD The Annals of Thoracic Surgery Volume 100, Issue 2, Pages 542-549 (August 2015) DOI: 10.1016/j.athoracsur.2015.02.093 Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Distribution of the United Network for Organ Sharing status at the time of transplantation for patients undergoing orthotopic heart transplantation stratified into virgin chest (VC; green bars), bridge to transplantation (BTT; red bars), and prior sternotomy (PS; blue bars) cohorts. The Annals of Thoracic Surgery 2015 100, 542-549DOI: (10.1016/j.athoracsur.2015.02.093) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Kaplan-Meier survival analysis for patients undergoing orthotopic heart transplantation grouped by virgin chest (VC; green line), bridge to transplantation (BTT; red line), and prior sternotomy (PS; blue line). The Annals of Thoracic Surgery 2015 100, 542-549DOI: (10.1016/j.athoracsur.2015.02.093) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions